140 related articles for article (PubMed ID: 10640301)
41. Blunted pancreatic polypeptide-induced vasodilatation in mesenteric resistance vessels from spontaneously hypertensive rats.
Gradin KA; Li JY; Zhu H; Simonsen U
Eur J Pharmacol; 2008 Dec; 601(1-3):118-23. PubMed ID: 18851959
[TBL] [Abstract][Full Text] [Related]
42. VIP activates G(s) and G(i3) in rat alveolar macrophages and G(s) in HEK293 cells transfected with the human VPAC(1) receptor.
Shreeve SM; Sreedharan SP; Hacker MP; Gannon DE; Morgan MJ
Biochem Biophys Res Commun; 2000 Jun; 272(3):922-8. PubMed ID: 10860852
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).
Olianas MC; Maullu C; Adem A; Mulugeta E; Karlsson E; Onali P
Br J Pharmacol; 2000 Oct; 131(3):447-52. PubMed ID: 11015294
[TBL] [Abstract][Full Text] [Related]
44. Regulation of K+ and Ca++ channels by a family of neuropeptide Y receptors.
Sun L; Philipson LH; Miller RJ
J Pharmacol Exp Ther; 1998 Feb; 284(2):625-32. PubMed ID: 9454807
[TBL] [Abstract][Full Text] [Related]
45. High affinity displacement of [(3)H]NPY binding to the crude venom of conus anemone by insect neuropeptides.
Le MT; Vanderheyden PM; De Backer JP; Vanquelin G; Broeck JV
Biochem Biophys Res Commun; 1999 Aug; 262(1):180-6. PubMed ID: 10448089
[TBL] [Abstract][Full Text] [Related]
46. Stable expression of the recombinant human VIP1 receptor in clonal Chinese hamster ovary cells: pharmacological, functional and molecular properties.
Gaudin P; Couvineau A; Maoret JJ; Rouyer-Fessard C; Laburthe M
Eur J Pharmacol; 1996 Apr; 302(1-3):207-14. PubMed ID: 8791009
[TBL] [Abstract][Full Text] [Related]
47. Multiplicity of neuropeptide Y receptors: cloning of a third distinct subtype in the zebrafish.
Ringvall M; Berglund MM; Larhammar D
Biochem Biophys Res Commun; 1997 Dec; 241(3):749-55. PubMed ID: 9434780
[TBL] [Abstract][Full Text] [Related]
48. Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor.
Parker SL; Kane JK; Parker MS; Berglund MM; Lundell IA; Li MD
Eur J Biochem; 2001 Feb; 268(4):877-86. PubMed ID: 11179953
[TBL] [Abstract][Full Text] [Related]
49. Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors.
Bhattacharya S; Linden J
Mol Pharmacol; 1996 Jul; 50(1):104-11. PubMed ID: 8700102
[TBL] [Abstract][Full Text] [Related]
50. Neuropeptide Y enhances ATP-induced formation of inositol phosphates in chromaffin cells.
Zheng J; Zhang P; Toews M; Hexum TD
Biochem Biophys Res Commun; 1997 Oct; 239(1):287-90. PubMed ID: 9345312
[TBL] [Abstract][Full Text] [Related]
51. Molecular characterization of the human neuropeptide Y Y2-receptor.
Ingenhoven N; Eckard CP; Gehlert DR; Beck-Sickinger AG
Biochemistry; 1999 May; 38(21):6897-902. PubMed ID: 10346911
[TBL] [Abstract][Full Text] [Related]
52. Studies of the human, rat, and guinea pig Y4 receptors using neuropeptide Y analogues and two distinct radioligands.
Berglund MM; Lundell I; Eriksson H; Söll R; Beck-Sickinger AG; Larhammar D
Peptides; 2001 Mar; 22(3):351-6. PubMed ID: 11287089
[TBL] [Abstract][Full Text] [Related]
53. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY.
Lundell I; Blomqvist AG; Berglund MM; Schober DA; Johnson D; Statnick MA; Gadski RA; Gehlert DR; Larhammar D
J Biol Chem; 1995 Dec; 270(49):29123-8. PubMed ID: 7493937
[TBL] [Abstract][Full Text] [Related]
54. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Br J Pharmacol; 2003 Aug; 139(7):1360-8. PubMed ID: 12890716
[TBL] [Abstract][Full Text] [Related]
55. Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors.
Nakamura M; Sakanaka C; Aoki Y; Ogasawara H; Tsuji T; Kodama H; Matsumoto T; Shimizu T; Noma M
J Biol Chem; 1995 Dec; 270(50):30102-10. PubMed ID: 8530415
[TBL] [Abstract][Full Text] [Related]
56. Control of signalling efficacy by palmitoylation of the rat Y1 receptor.
Holliday ND; Cox HM
Br J Pharmacol; 2003 Jun; 139(3):501-12. PubMed ID: 12788810
[TBL] [Abstract][Full Text] [Related]
57. Expression of functional Y1 receptors for neuropeptide Y in human Ewing's sarcoma cell lines.
van Valen F; Winkelmann W; Jürgens H
J Cancer Res Clin Oncol; 1992; 118(7):529-36. PubMed ID: 1320624
[TBL] [Abstract][Full Text] [Related]
58. Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells shows strong preference for NPY, endosome-linked entry and fast receptor recycling.
Parker SL; Parker MS; Lundell I; Balasubramaniam A; Buschauer A; Kane JK; Yalcin A; Berglund MM
Regul Pept; 2002 Jul; 107(1-3):49-62. PubMed ID: 12137966
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological characterization of the mouse NPFF2 receptor.
Talmont F; Moulédous L; Piedra-Garcia L; Schmitt M; Bihel F; Bourguignon JJ; Zajac JM; Mollereau C
Peptides; 2010 Feb; 31(2):215-20. PubMed ID: 19944730
[TBL] [Abstract][Full Text] [Related]
60. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin.
Kane JK; Tanaka H; Parker SL; Yanagisawa M; Li MD
Biochem Biophys Res Commun; 2000 Jun; 272(3):959-65. PubMed ID: 10860858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
